J H Fairbanks MD PLLC

J H Fairbanks MD PLLC was paid $5.71M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 25% of everything it billed.

33Billing provider infoJ H FAIRBANKS MD PLLC
VIDALIA, LA 39120

33aNPI1336209550assigned 12/11/2006

33bProvider typeOrthopaedic Surgery Physician

28Total paid$5.71M

24GClaims178,658

24DCodes billed52

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Orthopaedic Surgery Physician providers in Louisiana

Rank by total paid#2 of 46

Median peer was paid$10K

This provider vs. median550×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	17,676	$487K
2019	18,554	$529K
2020	23,178	$822K
2021	25,723	$1.05M
2022	33,386	$1.19M
2023	38,384	$993K
2024incomplete	21,757	$642K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	25%	39,803	31,408	$1.40M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	34,090	28,201	$853K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	14%	23,354	18,474	$778K
L0648	Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf	6.7%	711	595	$382K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.6%	4,566	3,862	$318K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	4.4%	9,767	2,396	$253K
72110		3.6%	8,670	7,630	$203K
97530	Therapeutic activities, direct patient contact, each 15 minutes	3.2%	9,270	2,249	$180K
62323		3.0%	1,416	1,317	$174K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	2.9%	3,039	2,898	$165K
20611		2.3%	2,986	2,534	$129K
95913		2.2%	933	730	$125K

40 more codes

95886		2.0%	2,842	$112K
72170		1.6%	7,556	$92K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.4%	4,818	$79K
72040		1.1%	4,129	$64K
72052		1.0%	2,090	$60K
95912		<1%	470	$55K
73030		<1%	4,110	$54K
99205	Prolong outpt/office vis	<1%	452	$38K
97162		<1%	889	$36K
73564		<1%	1,772	$27K
99215	Doctor's office visit, returning patient (complex)	<1%	631	$24K
73565		<1%	1,350	$20K
72114		<1%	655	$15K
73562		<1%	1,578	$15K
73502		<1%	524	$11K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	252	$10K
72072		<1%	399	$8K
76881		<1%	156	$5K
73630		<1%	309	$5K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	310	$3K
73130		<1%	161	$3K
73610		<1%	139	$2K
95911		<1%	17	$2K
80305		<1%	160	$1K
20606		<1%	30	$1K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	126	$966.26
99201		<1%	41	$933.96
99443		<1%	39	$748.53
72100		<1%	31	$563.27
99442		<1%	28	$479.21
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	151	$396.82
72050		<1%	16	$347.04
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	28	$284.79
99441		<1%	38	$263.38
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	3,402	$245.21
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	44	$26.86
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	104	$22.22
99406		<1%	76	$12.27
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	110	$9.39
77003		0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNUGENT, ANGEL (MANAGER)

Parent organizationJ H FAIRBANKS MD PLLC